Results for tag: "Cataract Drug"

The Cataract Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat a variety of eye conditions. Cataract drugs are used to treat cataracts, a condition in which the lens of the eye becomes cloudy, resulting in blurred vision. Cataract drugs are typically administered as eye drops or injections, and can help to improve vision and reduce the risk of further vision loss. Cataract drugs are typically prescribed by ophthalmologists, and are often used in combination with other treatments such as surgery. In some cases, cataract drugs may be used to delay the need for surgery. The Cataract Drug market is highly competitive, with a number of companies offering products for the treatment of cataracts. Some of the major players in the market include Allergan, Bausch + Lomb, Santen Pharmaceuticals, and Novartis. Show Less Read more